Delivery Order SPE2DB22D2214-SPE2DB25FS4BL
Award Date 3/5/25
Potential Completion Date 3/6/25
Potential Value $5.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide TRESIBA FLEXTOUCH 200 UNIT/ML 3ML. The contract has a ceiling value of $7,331.88 and a performance period through July 9, 2025. AmerisourceBergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle for military and...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,094.60 firm fixed-price delivery order is for the supply of TRESIBA FLEXTOUCH 200 UNIT/ML 3ML, a specialty medication. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November 2026. The IDC...
- This is a delivery order under a broader Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,202.48 delivery order is for the supply of TRESIBA FLEXTOUCH 200 UNIT/ML 3ML, a prescription medication. This delivery order falls under the larger DLA Troop Support Medical IDC, valued at up to $999,999,999, which provides a range of medical commodities and pharmaceuticals to...
- This federal contract award, valued at $17,126.05, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for TRESIBA FLEXTOUCH 200 UNIT/ML 3ML, a prescription medication. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,904.98 firm fixed-price delivery order is for the supply of TRESIBA FLEXTOUCH 200 UNIT/ML 3ML, a diabetes medication. The contract has an ultimate completion date of March 24, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TRESIBA FLEXTOUCH 200 UNIT/ML 3ML pharmaceutical products, with a ceiling value of $1,348.08. The contract is a firm-fixed price delivery order, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TRESIBA FLEXTOUCH 200 UNIT/ML 3ML, a diabetes medication, with a ceiling value of $50,218.49 and a performance period ending on June 26, 2025. The contract is not set aside and was competed openly. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,332.94 firm fixed-price contract is for the supply of TRESIBA FLEXTOUCH 200 UNIT/ML 3ML, a diabetes medication. The delivery order has a June 2025 completion date and is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TRESIBA FLEXTOUCH 200 UNIT/ML 3ML, a specialty diabetes medication, with a ceiling value of $12,601.21 and a period of performance through April 4, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of TRESIBA FLEXTOUCH 200 UNIT/ML 3ML, a prescription medication. The $3,482.42 firm fixed price award has a completion date of July 25, 2024. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with DLA and other federal agencies for the provision of a wide range of pharmaceutical and medical products, including critical...
- SPE2DB22D2214Indefinite Delivery Contract
- SPE2DB22D2214-SPE2DB25FS4BLDelivery Order
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of TRESIBA FLEXTOUCH 200 UNIT/ML 3ML, a prescription medication. The delivery order, valued at $5,209.32, is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, worth up to $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award did not have a set-aside designation, indicating open competition.
Generated 7/1/25, 8:25 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.2k | 3/5/25 |